Michael J. Valentino
2020
In 2020, Michael J. Valentino earned a total compensation of $1.1M as Executive Chairman and Director at Dipexium Pharmaceuticals, a 62% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,250 |
|---|---|
| Option Awards | $696,800 |
| Salary | $250,000 |
| Total | $1,103,050 |
Valentino received $696.8K in option awards, accounting for 63% of the total pay in 2020.
Valentino also received $156.3K in non-equity incentive plan and $250K in salary.
Rankings
In 2020, Michael J. Valentino's compensation ranked 8,216th out of 13,090 executives tracked by ExecPay. In other words, Valentino earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,216 out of 13,090 | 37th |
Division Manufacturing | 3,487 out of 5,620 | 38th |
Major group Chemicals And Allied Products | 1,406 out of 2,253 | 38th |
Industry group Drugs | 1,224 out of 1,953 | 37th |
Industry Pharmaceutical Preparations | 910 out of 1,458 | 38th |
Source: SEC filing on September 29, 2022.
Valentino's colleagues
We found two more compensation records of executives who worked with Michael J. Valentino at Dipexium Pharmaceuticals in 2020.